Article: Center for Molecular Medicine Selected to Provide DNA Analysis for Children's Oncology Group Leukemia Study.

World's Largest Childhood Cancer Research Organization Looks to CMM for Professional Services in Finding Genetic Markers That May Improve Treatment

GRAND RAPIDS, Mich., Jan. 8 /PRNewswire/ -- The Center for Molecular Medicine (CMM) today announced it has been selected by the Children's Oncology Group (COG) to provide professional genotyping services and analysis as part of a study to evaluate the existence of genetic abnormalities and their association with response to therapy and/or specific toxicities to improve the diagnosis and treatment of childhood leukemia.

In Phase I of the study, the CMM has been asked to provide extensive testing and review ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!